Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma

Clinical trial NCT00883688 · COMPLETED

Trial details

NCT number: NCT00883688
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Cancer Pediatric Cancers

Start date: 2009-07-01
Primary completion: 2015-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.